12 Babies Die During a Vaccine Trial

Twelve babies have died during a vaccine trial over the last year. So why haven’t you heard about it? Well, for one it is because the trial has been conducted in Argentina on impoverished individuals who have no resources to raise their voices. What’s more telling? The first one to break the story in the United States was a stock market investment website. The story wasn’t being told to raise red flags or warn the public, to investigate the morality or integrity of the company’s practices, or to spark further research. The article was newsworthy only from a financial perspective. To protect those who have an interest in whether or not to purchase stock from GlaxoSmithKline. Anyone who doesn’t believe that the driving force and bottom line of vaccination programs is about money is sorely mistaken.

Argentina was one of the countries chosen by GlaxoSmithKline to test the effectiveness of a vaccine against pneumonia. They use children from poor families who are “pressured and forced into signing consent forms.” Juan Carlos Palomares, who works for the Argentine Federation of Health Professionals, also known as Fesprosa, said that “in most cases these are underprivileged individuals, many of them unable to read or write, who are pressured into including their children” in these trials. Does anyone else catch the irony in that? How are those who are unable to read and write able to give appropriate consent when they cannot even read the consent forms they are signing? Why is this acceptable in another country but not in our own. This is after all an American business so why would we tolerate this type of behavior? Why do we turn our heads and shrug? Perhaps as long as the unethical business practices are not in our own back yard they are acceptable. Since GlaxoSmithKline can’t perform these types of studies in the United States or Europe, “they come to do it in third-world countries.” I find this completely wrong and I’m not afraid to say so. If we, as Americans, want and feel that a vaccine program is so life saving and so necessary to appropriate health care (which is the general consensus) then we need to be willing to conduct the studies on our own children and reform the laws to do so. But who will push forward their children and raise their hands for a vaccine trial. Would those working for GlaxoSmithKline? Would you? What does your answer tell you?

Many of the parents in the Argentina program have tried to pull out of the program only to find that those conducting the trial “force them to continue under the threat that if they leave they won’t receive any other vaccine,” said Julieta Ovejero, great aunt of one of the six babies who died in Santiago del Estero. Not only are the consent forms often illegitimate but the families are then threatened if they change their minds about participating. Yet, there is no outrage. There is no one sitting on the Dave Letterman show telling this story. There are no capitol marches. These are silent victims because they have no way to tell their stories and would anyone care anyway even if they did? This is the untold story of our vaccine program and this is just one vaccine trial in only one country. There are many, many more.

In the end, it is only twelve babies, right? Isn’t that within the realm of acceptable deaths? What is the number of acceptable deaths that we will tolerate? Despite the deaths that have all ready occurred the program continues on and GlaxoSmithKline accepts the number of deaths as a necessary part of the numbers game. They count on you accepting that as well. In fact, they spend quite a bit of research trying to determine exactly what the number of deaths the American public will accept in order to reach a 90% acceptance rate. Keep in mind that we only have the reported number of deaths. How many side effects have occurred or are yet to occur? Will these trials be an accurate reflection of the outcome we’ll see when this vaccine makes it to the general public? Or will there be yet another vaccine fallout like the one being experienced with the Gardasil vaccine which is quickly becoming a ticking time bomb?

Take a look at the most recent Gardasil statistics, a HPV vaccine recommended for young girls and women. The statistics were gained from HERE.

The Judicial Watch Special Report, Examining the FDA’s HPV Vaccine Records, dated June 30, 2008, reviews records obtained from the FDA under the provisions of the Freedom of Information Act. Those records paint an even grimmer version of this dangerous vaccine, whose side effects now include:

· A total of 8,864 reported adverse events

· A minimum of 18, but possibly 20 reported deaths. 11 occurred less than one week after vaccination, and 7 within two days

· 45 cases of miscarriages and spontaneous abortions

· 78 outbreaks of genital warts, plus additional cases of facial warts and warts on hands and feet, even in patients who had tested negative for HPV and genital warts prior to vaccination

Additionally, Merck correspondence included in these records state that Gardasil has NOT been evaluated for its potential to cause carcinogenity or genotoxicity, AND, they were permitted to use an aluminum-containing placebo instead of a standard saline placebo.

Since Gardasil contains 225 mcg of aluminum, using an aluminum-containing placebo may paint an entirely inaccurate picture of its level of safety.

For reference, here is the original article on the pneumonia vaccine trial being conducted in Argentina that first appeared on TradingMarkets.com

Buenos Aires, Jul 10, 2008 (EFE via COMTEX) — HPFS | Quote | Chart | News | PowerRating — At least 12 babies who were part of a clinical study to test the effectiveness of a vaccine against pneumonia have died over the past year in Argentina, the local press reported Thursday.

The study was sponsored by global drug giant GlaxoSmithKline and uses children from poor families, who are “pressured and forced into signing consent forms,” the Argentine Federation of Health Professionals, or Fesprosa, said.

“This occurs without any type of state control” and “does not comply with minimum ethical requirements,” Fesprosa said.

The vaccine trial is still ongoing despite the denunciations, and those in charge of the study were cited by the Critica newspaper as saying that the procedures are being carried out in a lawful manner.

Colombian and Panama were also chosen by GSK as staging grounds for trials of the vaccine against the pneumococcal bacteria.

Since 2007, 15,000 children under the age of one from the Argentine provinces of Mendoza, San Juan and Santiago del Estero have been included in the research protocol, a statement of what the study is trying to achieve.

“Only 12 have died throughout the country, which is a very low figure if we compare it with the deaths produced by respiratory illnesses caused by the pneumococcal bacteria,” pediatrician Enrique Smith, one of the lead investigators, said.

In Santiago del Estero, one of the country’s poorest provinces, the trials were authorized when Enrique’s brother, Juan Carlos Smith, was provincial health minister.

According to pediatrician Ana Maria Marchese, who works at the children’s hospital in the provincial capital where the studies are being conducted, “because they can’t experiment in Europe or the United States, they come to do it in third-world countries.”

“A lot of people want to leave the protocol but aren’t allowed; they force them to continue under the threat that if they leave they won’t receive any other vaccine,” said Julieta Ovejero, great aunt of one of the six babies who died in Santiago del Estero.

Fesprosa’s Juan Carlos Palomares said that “in most cases these are underprivileged individuals, many of them unable to read or write, who are pressured into including their children” in the trials.

According to Fesprosa, “the laboratory pays $8,000 for each child included in the study, but none (of that money) remains in the province that lends the public facilities and the health personnel for the private research.” EFE


For full details on Glaxosmithkline Plc Adr (GSK) click here. Glaxosmithkline Plc Adr (GSK) has Short Term PowerRatings of 4. Details on Glaxosmithkline Plc Adr (GSK) Short Term PowerRatings is available at This Link.